Earnings History Data for Kezar Life Sciences, Inc. (KZR) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. is a bio-technology company. It discovers and develops molecule therapeutics and medicines such as protein homeostasis for autoimmune disorders. The company's product pipeline consists of KZR-616 which is in clinical stage. Kezar Life Sciences, Inc. is headquartered in South San Francisco, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-08-2024 | AH | KZR | Kezar Life Sciences | 41.00 | -0.28 | -0.32 | 0.00 | Kezar Life Sciences GAAP EPS of -$0.30 [8/14/2024 10:34 AM] |
0.6008 | 0.02 (3.55%) |
0.61 | 0.03 (5.14%) |
0.54 - 1.68 | 871,949 | 230,000 | 1,825 | ||
| 14-03-2024 | AH | KZR | Kezar Life Sciences | 68.00 | -0.35 | -0.39 | 0.00 | Kezar Life Sciences GAAP EPS of -$0.44 [3/14/2024 5:50 PM] |
0.8876 | 0.04 (4.42%) |
0.85 | 0.0 (0.00%) |
0.67 - 5.36 | 789,364 | 660,000 | 15,623 | ||
| 13-11-2023 | PM | KZR | Kezar Life Sciences | 54.00 | -0.32 | -0.36 | 0.00 | Kezar Life Sciences GAAP EPS of -$0.32 beats by $0.04, revenue of $7M beats by $6.7M [11/14/2023 1:54 AM] |
0.7840 | 0.06 (7.78%) |
0.77 | 0.04 (5.86%) |
0.67 - 8.25 | 967,076 | 360,000 | 22,727 | ||
| 10-08-2023 | PM | KZR | Kezar Life Sciences, Inc. | 148.43 | -0.34 | -0.33 | -0.25 | Kezar Life Sciences GAAP EPS of -$0.34 in-line [8/11/2023 4:07 AM] |
1.50 | -0.54 (-26.59%) |
2.05 | 0.0 (0.00%) |
1.35 - 10.78 | 1,385,508 | 230,000 | 7,766 | ||
| 14-03-2023 | AH | KZR | Kezar Life Sciences | 317.00 | -0.25 | -0.24 | 0.00 | Kezar Life Sciences GAAP EPS of -$0.25 beats by $0.03 [3/14/2023 4:52 PM] |
4.59 | -0.58 (-11.29%) |
5.18 | 0.0 (0.00%) |
4.30 - 18.55 | 650,602 | 970,000 | 14,946 | ||
| 10-11-2022 | AH | KZR | Kezar Life Sciences | 423.00 | -0.25 | -0.26 | 0.00 | Kezar Life Sciences GAAP EPS of -$0.25 [11/10/2022 5:14 PM] |
7.61 | 0.38 (5.26%) |
7.23 | 0.0 (0.00%) |
4.30 - 18.55 | 690,853 | 540,000 | 25,159 | ||
| 09-11-2021 | AH | KZR | Kezar Life Sciences | 412.00 | -0.28 | -0.26 | 0.00 | Kezar Life Sciences EPS misses by $0.02 [11/9/2021 4:56 PM] |
7.47 | -0.29 (-3.74%) |
7.76 | 0.0 (0.00%) |
4.61 - 9.79 | 268,559 | 290,000 | 131,431 | ||
| 12-08-2021 | AH | KZR | Kezar Life Sciences, Inc. | 283.73 | -0.25 | -0.26 | -0.22 | Kezar Life Sciences EPS beats by $0.01 [8/12/2021 5:08 PM] |
5.92 | 0.07 (1.20%) |
5.85 | 0.0 (0.00%) |
4.34 - 7.40 | 187,186 | 280,000 | 2,841 | ||
| 12-05-2021 | AH | KZR | Kezar Life Sciences, Inc. | 251.00 | -0.25 | -0.24 | 0.00 | Kezar Life Sciences EPS misses by $0.01 [5/12/2021 4:48 PM] |
5.14 | 0.21 (4.26%) |
4.90 | -0.03 (-0.61%) |
4.24 - 9.79 | 122,063 | 450,000 | 3,749 | ||
| 11-03-2021 | AH | KZR | Kezar Life Sciences, Inc. | 277.01 | -0.22 | -0.24 | -0.50 | Kezar Life Sciences reports Q4 results [3/11/2021 5:42 PM] |
6.82 | 0.26 (3.96%) |
6.56 | 0.0 (0.00%) |
2.18 - 9.79 | 157,655 | 203,827 | 2,803 | ||
| 05-08-2020 | AH | 4:00 PM ET (Aug 5) |
KZR | Kezar Life Sciences, Inc. | 200.01 | -0.22 | -0.26 | -0.46 | Kezar Life Sciences EPS beats by $0.04 [8/5/2020 4:08 PM] |
4.68 | -0.04 (-0.85%) |
4.38 | -0.34 (-7.20%) |
2.18 - 9.79 | 197,445 | 213,293 | 627 | |
|
|
||||||||||||||||||